United Therapeutics (UTHR) Falls after FDA Again Fails to Approve Oral Treprostinil NDA
Tweet Send to a Friend
United Therapeutics Corp (NASDAQ: UTHR) is down 4.7 percent in early trading Monday after the company said it received a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
